VYRITAK

Serial Number 77937019
606

Registration Progress

Application Filed
Feb 16, 2010
Under Examination
Aug 31, 2010
Approved for Publication
Jul 6, 2010
Published for Opposition
Jul 6, 2010
Registered

Basic Information

Serial Number
77937019
Filing Date
February 16, 2010
Published for Opposition
July 6, 2010
Abandonment Date
September 30, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 30, 2013
Classes
005

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
130 Waverly Street
Cambridge, MA 02139

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Cambridge, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description
Sep 30, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Sep 30, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 5, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2013 EX5G S SOU EXTENSION 5 GRANTED
Feb 1, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 1, 2013 EXT5 S SOU EXTENSION 5 FILED
Aug 10, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 9, 2012 EX4G S SOU EXTENSION 4 GRANTED
Aug 8, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 8, 2012 EXT4 S SOU EXTENSION 4 FILED
Feb 16, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2012 EX3G S SOU EXTENSION 3 GRANTED
Feb 14, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 14, 2012 EXT3 S SOU EXTENSION 3 FILED
Sep 2, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 1, 2011 EX2G S SOU EXTENSION 2 GRANTED
Aug 31, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 30, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 28, 2011 EXT2 S SOU EXTENSION 2 FILED
Feb 26, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 24, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 24, 2011 EXT1 S SOU EXTENSION 1 FILED
Feb 24, 2011 EX1G S SOU EXTENSION 1 GRANTED
Aug 31, 2010 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 6, 2010 PUBO A PUBLISHED FOR OPPOSITION
Jul 6, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2010 ALIE A ASSIGNED TO LIE
Jun 2, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
May 19, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2010 DOCK D ASSIGNED TO EXAMINER
Feb 19, 2010 NWAP I NEW APPLICATION ENTERED
Feb 19, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of viral diseases, bacterial infections, cystic fibrosis, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005